Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 47 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 37 | 1,683−5.9%/yr | −5.9%/yr | 3.91.2× | 38% | 1,690 in 20300%/yr |
| Lumbar fusion | 23 | 1,070−2.7%/yr | −2.7%/yr | 2.50.9× | 2% | 1,000 in 2030−1.2%/yr |
| Cervical fusion & disc arthroplasty | 11 | 615−5.6%/yr | −5.6%/yr | 1.41.1× | 25% | 690 in 2030+2%/yr |
| Kyphoplasty & vertebroplasty | 0 | 181−0.7%/yr | −0.7%/yr | 0.40.5× | 100% | 310 in 2030+9.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 122 | 18,431−5.2%/yr | −5.2%/yr | 41.80.4× | 49% | 21,500 in 2030+2.6%/yr |
| Skin substitutes & wound grafts | 20 | 3,597+11%/yr | +11%/yr | 5.00.4× | 89% | 4,970 in 2030+5.5%/yr |
| Bone graft & orthobiologics | 9 | 416−2.9%/yr | −2.9%/yr | 1.01.2× | 3% | 440 in 2030+0.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 49 | 3,673+3.6%/yr | +3.6%/yr | 8.30.8× | 97% | 5,130 in 2030+5.7%/yr |
| Spinal cord & DRG stimulation | 11 | 336−6%/yr | −6%/yr | 0.71.2× | 95% | 480 in 2030+6.2%/yr |
| Peripheral nerve stimulation & intrathecal pumps | 4 | 325+4.4%/yr | +4.4%/yr | 0.70.8× | 91% | 1,740 in 2030+32%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Peripheral arterial intervention | 14 | 1,434−4.5%/yr | −4.5%/yr | 3.30.6× | 63% | 1,890 in 2030+4.7%/yr |
| Dialysis access | 16 | 1,041−9.9%/yr | −9.9%/yr | 2.60.5× | 56% | 1,090 in 2030+0.7%/yr |
| Superficial venous ablation | 18 | 938−1%/yr | −1%/yr | 2.10.4× | 96% | 960 in 2030+0.4%/yr |
| Carotid revascularization | 8 | 425−4.9%/yr | −4.9%/yr | 1.01.2× | 0% | 460 in 2030+1.4%/yr |
| Thrombectomy, IVC filters & venous stents | 2 | 343+2.3%/yr | +2.3%/yr | 0.80.7× | 0% | 370 in 2030+1.1%/yr |
| Aortic endografts (EVAR/TEVAR) | 0 | 169−9.9%/yr | −9.9%/yr | 0.41.3× | 0% | 170 in 2030−0.3%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 23 | 2,486−2.6%/yr | −2.6%/yr | 6.31.1× | 10% | 3,210 in 2030+4.4%/yr |
| Cholecystectomy & appendectomy | 12 | 1,552−4.6%/yr | −4.6%/yr | 3.81.0× | 1% | 1,830 in 2030+2.8%/yr |
| Colorectal resection | 1 | 627−4.1%/yr | −4.1%/yr | 1.51.1× | 0% | 710 in 2030+2%/yr |
| Antireflux & hiatal hernia surgery | 3 | 328−6.4%/yr | −6.4%/yr | 0.81.1× | 0% | 390 in 2030+2.9%/yr |
| Breast reconstruction | 0 | 119−15%/yr | −15%/yr | 0.30.7× | 48% | 130 in 2030+1.7%/yr |
| Bariatric surgery | 0 | 117−11%/yr | −11%/yr | 0.31.8× | 0% | 100 in 2030−2.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| BPH procedures | 25 | 1,987−8.3%/yr | −8.3%/yr | 4.71.0× | 44% | 1,720 in 2030−2.4%/yr |
| Kidney stone management | 48 | 1,607−2.1%/yr | −2.1%/yr | 3.91.1× | 18% | 1,870 in 2030+2.6%/yr |
| Hysterectomy, hysteroscopy & ablation | 10 | 1,031+0.7%/yr | +0.7%/yr | 2.71.2× | 14% | 1,100 in 2030+1.1%/yr |
| Incontinence, prolapse & sacral neuromodulation | 11 | 883−0.6%/yr | −0.6%/yr | 2.11.1× | 21% | 1,300 in 2030+6.6%/yr |
| Prostatectomy & nephrectomy | 10 | 568−2.4%/yr | −2.4%/yr | 1.51.3× | 0% | 610 in 2030+1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 13 | 1,298−4.4%/yr | −4.4%/yr | 3.10.7× | 88% | 1,460 in 2030+2%/yr |
| Ear tubes & middle ear surgery | 0 | 105−2.8%/yr | −2.8%/yr | 0.31.2× | 0% | 120 in 2030+1.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 39 | 2,381−1.7%/yr | −1.7%/yr | 6.11.0× | 34% | 2,430 in 2030+0.3%/yr |
| Tumor & fibroid embolization | 6 | 355+8.7%/yr | +8.7%/yr | 0.91.5× | 30% | 460 in 2030+4.5%/yr |
| Tumor ablation | 0 | 120+0.7%/yr | +0.7%/yr | 0.31.1× | 0% | 140 in 2030+2.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 67 | 6,744+25%/yr | +25%/yr | 15.80.8× | 74% | 15,000 in 2030+14%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 32 | 1,588−2.2%/yr | −2.2%/yr | 4.01.0× | 3% | 1,810 in 2030+2.2%/yr |
| EP ablation | 25 | 1,089+4.8%/yr | +4.8%/yr | 2.10.7× | 0% | 1,910 in 2030+9.9%/yr |
| LAA occlusion & loop recorders | 19 | 718+9.3%/yr | +9.3%/yr | 1.50.5× | 5% | 1,330 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 40 | 1,758−7.7%/yr | −7.7%/yr | 3.40.7× | 2% | 1,840 in 2030+0.7%/yr |
| Structural heart (TAVR, TEER) | 39 | 802+2.6%/yr | +2.6%/yr | 1.61.1× | 0% | 1,140 in 2030+6%/yr |
| Mechanical circulatory support | 0 | 153−4.9%/yr | −4.9%/yr | 0.40.8× | 0% | 280 in 2030+11%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Stroke thrombectomy | 1 | 130−4.5%/yr | −4.5%/yr | 0.30.8× | 0% | 270 in 2030+13%/yr |
| DBS & VNS | 2 | 124−13%/yr | −13%/yr | 0.30.9× | 0% | 140 in 2030+1.9%/yr |
| Aneurysm & intracranial embolization | 2 | 108+11%/yr | +11%/yr | 0.30.5× | 0% | 150 in 2030+5.8%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 132 | 19,5390%/yr | 0%/yr | 45.71.0× | 85% | 23,200 in 2030+2.9%/yr |
| Vitreoretinal surgery | 16 | 1,238−2.8%/yr | −2.8%/yr | 3.01.1× | 41% | 1,270 in 2030+0.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 259 | 35,214−3%/yr | −3%/yr | 87.60.8× | 43% | 37,100 in 2030+0.9%/yr |
| ERCP & endoscopic ultrasound | 26 | 1,050−5.1%/yr | −5.1%/yr | 2.60.7× | 0% | 1,370 in 2030+4.6%/yr |
| Bronchoscopy & lung nodule | 10 | 796+5.6%/yr | +5.6%/yr | 1.90.8× | 0% | 1,500 in 2030+11%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.